CASI Pharmaceuticals Inc (CASI)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CASI market cap is 34.01M. The company's latest EPS is USD -1.7438 and P/E is -1.26.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.57M | 10.21M | 15.26M | 8.35M | 9.82M |
| Operating Income | -7.75M | -6.35M | -13.83M | -7.27M | -9.3M |
| Net Income | -7.68M | -5.2M | -19.54M | -6.01M | -10.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.13M | 15.14M | 30.17M | 43.11M | 40.25M |
| Operating Income | -46.96M | -52.68M | -41.84M | -35.22M | -25.28M |
| Net Income | -46.03M | -48.29M | -38.05M | -41.01M | -26.96M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 118.86M | 127.91M | 96.23M | 88.4M | 77.87M |
| Total Liabilities | 29.25M | 44.69M | 29.3M | 26.17M | 24.03M |
| Total Equity | 66.94M | 61.71M | 44.57M | 39.58M | 32.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 102.63M | 127.73M | 138.3M | 96.23M | 75.27M |
| Total Liabilities | 8.97M | 24.16M | 30.34M | 29.3M | 51.1M |
| Total Equity | 73M | 81.54M | 84.5M | 44.57M | 24.17M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.72M | -20.25M | -21.09M | N/A | N/A |
| Investing | -3.25M | 13.21M | 31.16M | N/A | N/A |
| Financing | -2M | N/A | -3.27M | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.24M | -25.89M | -26.84M | -21.09M | -19.97M |
| Investing | -28.06M | -20.72M | -20.69M | 31.16M | -9.67M |
| Financing | 22.05M | 47.15M | 29.64M | -3.27M | -907k |
| Market Cap | 34.01M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 0.85 |
| Price to Cash Ratio | 1.99 |
| Price to Book Ratio | 1.41 |
| Dividend Yield | - |
| Shares Outstanding | 15.46M |
| Average Volume (1 week) | 5.67k |
| Average Volume (1 Month) | 8.6k |
| 52 Week Change | -59.48% |
| 52 Week High | 7.67 |
| 52 Week Low | 2.05 |
| Spread (Intraday) | 0.22 (9.24%) |
| Company Name | CASI Pharmaceuticals Inc |
| Address |
po box 309, ugland house grand cayman KY1-1104 |
| Website | https://www.casipharmaceuticals.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
